Immunovant(DE:4YB)
DE:4YB
Immunovant earnings date
Immunovant (4YB) Q4 2023 Earnings Report
0 Followers
DE:4YB Q4 2023 EPS Results
- Actual EPS
- -EUR 0.41
- Consensus EPS
- -EUR 0.38
- Beat/Miss
- Missed by -EUR 0.03
- One Year Ago EPS
- -EUR 0.37
DE:4YB Q4 2023 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q4 2023
- Date
- 05/22/2023
- Time
- Before Open
- Conference Call
- Monday, May 22, 2023
DE:4YB Upcoming Earnings
Immunovant's next earnings date is estimated for February 16, 2027, based on past reporting schedules.
Q4 2023 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:4YB Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 16, 2027 | 2027 (Q3) | -0.53- | -0.55 | ― | ― |
| Nov 09, 2026 | 2027 (Q2) | -0.66-0.42 | -0.66 | 35.62% (+0.23) | |
| Aug 06, 2026 | 2027 (Q1) | -0.57-0.68 | -0.64 | -5.63% (-0.04) | |
| May 20, 2026 | 2026 (Q4) | -0.53-0.66 | -0.58 | -14.06% (-0.08) | |
| Feb 06, 2026 | 2026 (Q3) | -0.64-0.55 | -0.68 | 19.74% (+0.14) | |
| Nov 10, 2025 | 2026 (Q2) | -0.64-0.66 | -0.67 | 1.35% (+0.01) | |
| Aug 11, 2025 | 2026 (Q1) | -0.61-0.64 | -0.54 | -18.33% (-0.10) | |
| May 29, 2025 | 2025 (Q4) | -0.64-0.58 | -0.47 | -23.08% (-0.11) | |
| Feb 06, 2025 | 2025 (Q3) | -0.68-0.68 | -0.26 | -162.98% (-0.42) | |
| Nov 07, 2024 | 2025 (Q2) | -0.54-0.67 | -0.41 | -64.44% (-0.26) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
